Psychedelics Alaska senate considers psychedelics task force proposal Legislation anticipates federal legalization, establishes the Alaska Mental Health and Psychedelics Medicine Task Force Zartasha MushtaqFebruary 7, 2024
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Business Numinus submits novel psilocybe formulation for clinical trial If approved, it will mark the firm's first independent clinical trial with a proprietary extract Nick LabaJanuary 14, 2022
News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
Culture Becoming light through the darkness: My first ibogaine trip Writer Suzannah Weiss details her experience of physical and mental healing, accompanied by comic illustrations Suzannah WeissMay 14, 2021
Industry update Mydecine to make first legal import of psilocybin mushrooms into Canada Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments Jared GnamDecember 11, 2020
Cannabis Havn wants to turn hard lessons into psychedelic gold Many of the firm's well-known faces took lumps in the weed sector, mistakes they say set them up for success in psychedelics Nick LabaOctober 13, 2020
The weed wire Psychedelic treatment firm enters NIH research deal CaaMTech will be researching synthetic tryptamine-based compounds as part of a cooperative R&D program Nick LabaMay 7, 2020